ArticleMolecular imaging
Absolute Quantitative Photoacoustic Imaging for Contrast Agents Concentration Estimation Using a Spectral Decomposition Approach.
Article in Molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In-bore MRI-compatible transrectal ultrasound and photoacoustic imaging.Photoacoustics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Photoacoustic (PA) imaging is a promising modality for medical diagnostics and therapeutic monitoring, but accurate quantification of contrast agents (CAs) remains a challenge due to nonlinear signal responses and spectral shifts at varying concentrations. These limitations hinder its clinical utility in applications such as tumor detection and treatment monitoring. This study introduces a spectral decomposition method to improve absolute CA concentration estimation in PA imaging. By using a reference spectral library, the approach corrects for signal distortions and nonlinear behavior, overcoming key limitations of traditional intensity-based methods. Validation was performed through in vitro experiments using a prostate-specific membrane antigen (PSMA)-targeted CA in both saline and blood, as well as dynamic tracking of indocyanine green (ICG) in ex vivo tissue. The method achieved significantly lower concentration estimation errors, with average absolute errors of 1.80 µM in saline and 3.34 µM in blood. Compared to conventional techniques, the proposed method demonstrated enhanced reliability and robustness. These results underscore the potential of this spectral-based quantification technique to support more precise, clinically translatable PA imaging, enabling accurate CA measurement for early disease detection, surgical guidance, and real-time monitoring of therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.